Clinic
Lasalle Medical Associates
Lasalle Medical Associates was paid $3.27M by Medicaid between Jan 2018 and Nov 2024, across 475 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 15% of everything it billed.
33Billing provider infoLASALLE MEDICAL ASSOCIATES
REDLANDS, CA 92373
REDLANDS, CA 92373
33aNPI1891892535assigned 09/17/2006
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$3.27M
24GClaims525,238
24DCodes billed475
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in California
Rank by total paid#29 of 170
Median peer was paid$145K
This provider vs. median23×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 474,637 | $3.27M | |
| 2019 | 19,035 | $849.04 | |
| 2020 | 4,529 | $190.42 | |
| 2021 | 8,140 | $34.59 | |
| 2022 | 6,101 | $0.00 | |
| 2023 | 3,910 | $0.00 | |
| 2024incomplete | 8,886 | $114.51 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 105,908 | 95,883 | $479K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 6.9% | 5,496 | 5,436 | $224K |
| J3490 | Unclassified drugs | 6.4% | 1,102 | 979 | $210K |
| J0135 | Injection, adalimumab, 20 mg | 5.4% | 65 | 57 | $176K |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | 4.8% | 287 | 287 | $157K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.6% | 3,309 | 3,278 | $150K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4.2% | 3,524 | 2,106 | $138K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.1% | 9,213 | 8,718 | $135K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.1% | 2,588 | 2,564 | $134K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 2.7% | 167 | 167 | $88K |
| 59425 | 2.6% | 6,405 | 4,542 | $84K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2.3% | 679 | 678 | $74K |
463 more codes
| 59514 | 2.0% | 137 | $66K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.7% | 379 | $55K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.6% | 4,387 | $51K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.5% | 27,196 | $49K |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 1.3% | 507 | $41K |
| 71046 | Radiologic examination, chest; 2 views | 1.2% | 3,144 | $40K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 1.2% | 358 | $39K |
| 67028 | Intravitreal injection of a pharmacologic agent | 1.2% | 167 | $38K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.1% | 1,990 | $37K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 1.1% | 342 | $35K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 527 | $32K |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 158 | $28K |
| 99243 | <1% | 494 | $27K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 410 | $26K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 478 | $26K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 364 | $25K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 456 | $25K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 4,832 | $23K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,036 | $22K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 6,089 | $21K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,579 | $20K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 76 | $20K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 3,462 | $19K |
| 95886 | <1% | 130 | $17K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 51 | $17K |
| 76813 | <1% | 179 | $17K | |
| 97162 | <1% | 330 | $16K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,552 | $16K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 1,727 | $15K |
| 92250 | <1% | 103 | $15K | |
| 80053 | Comprehensive metabolic panel | <1% | 13,461 | $14K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 470 | $14K |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 108 | $12K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 1,081 | $11K |
| 95811 | <1% | 57 | $11K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 153 | $10K |
| A4267 | Contraceptive supply, condom, male, each | <1% | 262 | $9K |
| 92134 | <1% | 367 | $8K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 350 | $8K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 261 | $7K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 26 | $7K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,704 | $7K |
| 93880 | <1% | 62 | $7K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 158 | $6K |
| 73630 | <1% | 319 | $6K | |
| 95912 | <1% | 15 | $6K | |
| 76641 | <1% | 69 | $6K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 102 | $6K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 337 | $5K |
| 72100 | <1% | 197 | $5K | |
| T4532 | Pediatric sized disposable incontinence product, protective underwear/pull-on, large size, each | <1% | 133 | $5K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 69 | $5K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 14 | $5K |
| 99205 | Prolong outpt/office vis | <1% | 57 | $5K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 149 | $5K |
| 76801 | <1% | 73 | $5K | |
| 73562 | <1% | 221 | $5K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 6,090 | $5K |
| 97164 | <1% | 84 | $5K | |
| L3660 | Shoulder orthosis, figure of eight design abduction restrainer, canvas and webbing, prefabricated, off-the-shelf | <1% | 87 | $4K |
| 76830 | Ultrasound, transvaginal | <1% | 97 | $4K |
| 76642 | <1% | 48 | $4K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,667 | $4K |
| L0628 | Lumbar-sacral orthosis, flexible, provides lumbo-sacral support, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include stays, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf | <1% | 94 | $4K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 133 | $4K |
| 85018 | <1% | 15,925 | $4K | |
| 73030 | <1% | 188 | $4K | |
| 81025 | <1% | 7,391 | $4K | |
| 87510 | <1% | 248 | $4K | |
| 80184 | <1% | 15 | $4K | |
| 93224 | <1% | 35 | $4K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 156 | $3K |
| 87480 | <1% | 249 | $3K | |
| 93015 | <1% | 200 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 15,798 | $2K |
| 92235 | <1% | 42 | $2K | |
| 87797 | <1% | 208 | $2K | |
| 88307 | <1% | 44 | $2K | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | <1% | 50 | $2K |
| 97161 | <1% | 43 | $2K | |
| 81001 | <1% | 4,831 | $2K | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 24 | $2K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 22 | $2K |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 1,117 | $2K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,474 | $2K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 38 | $2K |
| 99223 | Prolong inpt eval add15 m | <1% | 25 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,089 | $2K |
| 71020 | <1% | 393 | $2K | |
| 95117 | <1% | 2,323 | $2K | |
| 88304 | <1% | 55 | $2K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 25 | $2K |
| 82542 | <1% | 53 | $1K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 129 | $1K |
| 86331 | <1% | 87 | $1K | |
| 99221 | <1% | 36 | $1K | |
| A5500 | For diabetics only, fitting (including follow-up), custom preparation and supply of off-the-shelf depth-inlay shoe manufactured to accommodate multi-density insert(s), per shoe | <1% | 25 | $1K |
| 72110 | <1% | 25 | $1K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 136 | $1K |
| 73130 | <1% | 74 | $1K | |
| 73610 | <1% | 59 | $1K | |
| 76770 | <1% | 12 | $968.64 | |
| 99241 | <1% | 13 | $950.52 | |
| 85610 | <1% | 990 | $907.89 | |
| 99242 | <1% | 45 | $896.51 | |
| T4526 | Adult sized disposable incontinence product, protective underwear/pull-on, medium size, each | <1% | 75 | $883.02 |
| 73110 | <1% | 56 | $879.90 | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 40 | $825.15 |
| 88342 | <1% | 51 | $814.26 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 9,979 | $780.67 |
| 99254 | <1% | 12 | $780.12 | |
| 80061 | Lipid panel | <1% | 8,965 | $767.11 |
| T4522 | Adult sized disposable incontinence product, brief/diaper, medium, each | <1% | 151 | $760.41 |
| T4541 | Incontinence product, disposable underpad, large, each | <1% | 518 | $752.71 |
| 86038 | <1% | 598 | $634.31 | |
| 72040 | <1% | 32 | $623.52 | |
| 84702 | <1% | 866 | $597.64 | |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | <1% | 12 | $588.00 |
| 94200 | <1% | 2,362 | $548.25 | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 27 | $540.00 |
| 99401 | <1% | 458 | $529.89 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 7,827 | $513.57 |
| 71010 | <1% | 71 | $500.41 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 708 | $491.28 |
| 99348 | <1% | 14 | $480.20 | |
| Q3014 | Telehealth originating site facility fee | <1% | 32 | $472.50 |
| 81003 | <1% | 2,557 | $447.33 | |
| 93000 | <1% | 616 | $429.81 | |
| 80306 | <1% | 152 | $370.91 | |
| 76536 | <1% | 12 | $358.44 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 40 | $345.03 |
| 85652 | <1% | 1,012 | $334.12 | |
| 94060 | <1% | 70 | $314.90 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,214 | $306.13 |
| 99000 | <1% | 3,848 | $304.96 | |
| 82247 | <1% | 228 | $304.34 | |
| T4535 | Disposable liner/shield/guard/pad/undergarment, for incontinence, each | <1% | 193 | $302.24 |
| 92552 | <1% | 823 | $300.66 | |
| 86431 | <1% | 496 | $275.94 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 13 | $275.25 |
| 85027 | <1% | 533 | $266.45 | |
| 84703 | <1% | 535 | $261.41 | |
| 83540 | <1% | 1,138 | $255.82 | |
| 95911 | <1% | 13 | $233.46 | |
| 86592 | <1% | 2,726 | $228.47 | |
| 90715 | <1% | 1,349 | $221.30 | |
| 88142 | <1% | 13 | $206.68 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,282 | $206.33 |
| 87070 | <1% | 1,116 | $205.08 | |
| 87660 | <1% | 45 | $204.68 | |
| 83735 | <1% | 1,241 | $201.85 | |
| 80074 | <1% | 267 | $200.53 | |
| 83001 | <1% | 337 | $199.56 | |
| 87077 | <1% | 202 | $198.33 | |
| 84484 | <1% | 552 | $196.80 | |
| 87081 | <1% | 1,126 | $190.86 | |
| 87806 | <1% | 15 | $183.47 | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 53 | $160.20 |
| 86200 | <1% | 320 | $154.06 | |
| 84403 | <1% | 237 | $151.99 | |
| 86803 | <1% | 353 | $143.31 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 432 | $140.24 |
| 82746 | <1% | 889 | $139.58 | |
| 86580 | <1% | 3,506 | $134.95 | |
| 82670 | <1% | 134 | $134.31 | |
| 90686 | <1% | 2,400 | $134.24 | |
| 92551 | <1% | 10,542 | $130.89 | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 57 | $128.07 |
| 81000 | <1% | 166 | $124.81 | |
| 83690 | <1% | 1,068 | $124.01 | |
| 86800 | <1% | 60 | $122.16 | |
| 81002 | <1% | 15,617 | $121.18 | |
| 84153 | <1% | 530 | $120.03 | |
| 73100 | <1% | 16 | $114.66 | |
| 87340 | <1% | 1,082 | $112.92 | |
| 84481 | <1% | 495 | $111.63 | |
| 82728 | <1% | 942 | $110.62 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 3,072 | $110.00 |
| 86850 | <1% | 1,057 | $107.18 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 399 | $104.07 |
| T4523 | Adult sized disposable incontinence product, brief/diaper, large, each | <1% | 68 | $95.04 |
| 84295 | <1% | 152 | $94.57 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 227 | $91.39 |
| 86171 | <1% | 90 | $88.00 | |
| 90633 | <1% | 1,087 | $86.49 | |
| 82310 | <1% | 166 | $86.19 | |
| 96156 | <1% | 1,730 | $84.30 | |
| 87088 | <1% | 250 | $78.72 | |
| T4527 | Adult sized disposable incontinence product, protective underwear/pull-on, large size, each | <1% | 95 | $77.76 |
| 82550 | <1% | 126 | $75.59 | |
| 84480 | <1% | 214 | $73.54 | |
| 90723 | <1% | 479 | $71.36 | |
| 87040 | <1% | 242 | $69.91 | |
| 86140 | <1% | 611 | $60.51 | |
| T4528 | Adult sized disposable incontinence product, protective underwear/pull-on, extra large size, each | <1% | 14 | $53.76 |
| 90647 | <1% | 530 | $52.42 | |
| 94010 | <1% | 901 | $49.20 | |
| 99384 | <1% | 93 | $48.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,109 | $47.99 |
| 84479 | <1% | 514 | $47.67 | |
| 96151 | <1% | 717 | $42.05 | |
| 83970 | <1% | 256 | $39.05 | |
| 90685 | <1% | 40 | $37.75 | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 132 | $37.60 |
| 83550 | <1% | 925 | $34.10 | |
| 81005 | <1% | 126 | $33.86 | |
| 96152 | <1% | 28 | $33.64 | |
| 86901 | <1% | 1,233 | $33.33 | |
| 84146 | <1% | 361 | $32.62 | |
| 92226 | <1% | 13 | $32.50 | |
| 90649 | <1% | 1,101 | $32.41 | |
| 96127 | <1% | 1,498 | $28.61 | |
| 83655 | <1% | 1,534 | $27.78 | |
| 80069 | <1% | 485 | $26.92 | |
| 82570 | <1% | 1,570 | $26.09 | |
| 85008 | <1% | 16 | $25.65 | |
| A5120 | Skin barrier, wipes or swabs, each | <1% | 74 | $25.00 |
| 86376 | <1% | 149 | $24.97 | |
| 87186 | <1% | 1,246 | $23.41 | |
| 90658 | <1% | 94 | $22.30 | |
| 86900 | <1% | 1,175 | $21.69 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,998 | $21.63 |
| 82951 | <1% | 166 | $20.92 | |
| 83880 | <1% | 273 | $19.47 | |
| 97803 | <1% | 278 | $18.78 | |
| A6402 | Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | <1% | 44 | $17.85 |
| 90680 | <1% | 478 | $17.84 | |
| 83605 | <1% | 288 | $17.35 | |
| 90696 | <1% | 43 | $16.74 | |
| 87210 | <1% | 29 | $15.30 | |
| 82274 | <1% | 1,448 | $14.37 | |
| 82150 | <1% | 215 | $14.11 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 261 | $14.10 |
| 90716 | <1% | 677 | $13.38 | |
| 80076 | <1% | 748 | $11.82 | |
| 85041 | <1% | 43 | $11.08 | |
| 85730 | <1% | 582 | $10.64 | |
| 82803 | <1% | 23 | $10.29 | |
| 84460 | <1% | 500 | $10.08 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 366 | $9.63 |
| 90657 | <1% | 46 | $8.92 | |
| 82043 | <1% | 2,108 | $5.08 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 88 | $4.46 |
| 99173 | <1% | 10,292 | $4.40 | |
| 87430 | <1% | 298 | $2.73 | |
| 87400 | <1% | 26 | $2.55 | |
| 86780 | <1% | 43 | $2.51 | |
| 85014 | 0% | 92 | $0.00 | |
| 92081 | 0% | 124 | $0.00 | |
| 3725F | 0% | 1,696 | $0.00 | |
| 80348 | 0% | 67 | $0.00 | |
| 82565 | 0% | 562 | $0.00 | |
| 93325 | 0% | 52 | $0.00 | |
| 84550 | 0% | 802 | $0.00 | |
| 82465 | 0% | 26 | $0.00 | |
| 90700 | 0% | 1,075 | $0.00 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 0% | 801 | $0.00 |
| 84439 | 0% | 3,198 | $0.00 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 239 | $0.00 |
| 87150 | 0% | 414 | $0.00 | |
| A4927 | Gloves, non-sterile, per 100 | 0% | 162 | $0.00 |
| 82947 | 0% | 864 | $0.00 | |
| 84155 | 0% | 132 | $0.00 | |
| 87045 | 0% | 89 | $0.00 | |
| 94664 | 0% | 716 | $0.00 | |
| 82248 | 0% | 191 | $0.00 | |
| 99072 | 0% | 861 | $0.00 | |
| 3078F | 0% | 653 | $0.00 | |
| 90648 | 0% | 561 | $0.00 | |
| 84100 | 0% | 878 | $0.00 | |
| 90670 | 0% | 2,063 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 1,863 | $0.00 |
| 90681 | 0% | 39 | $0.00 | |
| 83013 | 0% | 149 | $0.00 | |
| 87177 | 0% | 139 | $0.00 | |
| T1015 | A visit at a community health center or clinic (one all-in rate) | 0% | 388 | $0.00 |
| 83525 | 0% | 70 | $0.00 | |
| 82652 | 0% | 635 | $0.00 | |
| 84681 | 0% | 57 | $0.00 | |
| 90707 | 0% | 589 | $0.00 | |
| A4406 | Ostomy skin barrier, pectin-based, paste, per ounce | 0% | 13 | $0.00 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 0% | 518 | $0.00 |
| 86787 | 0% | 19 | $0.00 | |
| 80299 | 0% | 15 | $0.00 | |
| 85048 | 0% | 29 | $0.00 | |
| 90734 | 0% | 661 | $0.00 | |
| 3077F | 0% | 127 | $0.00 | |
| A6250 | Skin sealants, protectants, moisturizers, ointments, any type, any size | 0% | 246 | $0.00 |
| 86003 | 0% | 313 | $0.00 | |
| 80164 | 0% | 46 | $0.00 | |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 0% | 89 | $0.00 |
| 80361 | 0% | 67 | $0.00 | |
| 90713 | 0% | 618 | $0.00 | |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 138 | $0.00 |
| 82977 | 0% | 396 | $0.00 | |
| 86696 | 0% | 171 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 152 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 69 | $0.00 |
| 80364 | 0% | 28 | $0.00 | |
| 87481 | 0% | 1,161 | $0.00 | |
| 87209 | 0% | 139 | $0.00 | |
| 84156 | 0% | 355 | $0.00 | |
| 82785 | 0% | 157 | $0.00 | |
| 86235 | 0% | 28 | $0.00 | |
| 99152 | 0% | 97 | $0.00 | |
| 85045 | 0% | 468 | $0.00 | |
| 86708 | 0% | 227 | $0.00 | |
| 80326 | 0% | 28 | $0.00 | |
| 87075 | 0% | 119 | $0.00 | |
| 80365 | 0% | 67 | $0.00 | |
| 83516 | 0% | 190 | $0.00 | |
| 87427 | 0% | 98 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 12 | $0.00 |
| 82610 | 0% | 45 | $0.00 | |
| 88312 | 0% | 28 | $0.00 | |
| 83992 | 0% | 28 | $0.00 | |
| 86694 | 0% | 43 | $0.00 | |
| 99382 | 0% | 39 | $0.00 | |
| 3016F | 0% | 112 | $0.00 | |
| 80377 | 0% | 28 | $0.00 | |
| 87338 | 0% | 344 | $0.00 | |
| 86677 | 0% | 192 | $0.00 | |
| 84520 | 0% | 405 | $0.00 | |
| 80355 | 0% | 28 | $0.00 | |
| T4530 | Pediatric sized disposable incontinence product, brief/diaper, large size, each | 0% | 24 | $0.00 |
| 86480 | 0% | 54 | $0.00 | |
| 82627 | 0% | 26 | $0.00 | |
| 84450 | 0% | 501 | $0.00 | |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 0% | 72 | $0.00 |
| 80344 | 0% | 28 | $0.00 | |
| 80366 | 0% | 28 | $0.00 | |
| 80346 | 0% | 67 | $0.00 | |
| 11100 | 0% | 17 | $0.00 | |
| 80354 | 0% | 67 | $0.00 | |
| 80372 | 0% | 67 | $0.00 | |
| 80334 | 0% | 28 | $0.00 | |
| 87420 | 0% | 15 | $0.00 | |
| 80331 | 0% | 28 | $0.00 | |
| 80360 | 0% | 28 | $0.00 | |
| 90746 | 0% | 24 | $0.00 | |
| 87902 | 0% | 31 | $0.00 | |
| 90710 | 0% | 54 | $0.00 | |
| 90630 | 0% | 12 | $0.00 | |
| 80338 | 0% | 28 | $0.00 | |
| 11721 | 0% | 26 | $0.00 | |
| 82948 | 0% | 13 | $0.00 | |
| 80337 | 0% | 28 | $0.00 | |
| 80370 | 0% | 28 | $0.00 | |
| H1002 | Prenatal care, at risk enhanced service; care coordination | 0% | 16 | $0.00 |
| 80373 | 0% | 67 | $0.00 | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | 0% | 31 | $0.00 |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 0% | 27 | $0.00 |
| 95816 | 0% | 14 | $0.00 | |
| 99442 | 0% | 34 | $0.00 | |
| 72070 | 0% | 15 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 1,018 | $0.00 |
| 83615 | 0% | 267 | $0.00 | |
| 3074F | 0% | 766 | $0.00 | |
| 90651 | 0% | 400 | $0.00 | |
| 1031F | 0% | 9,113 | $0.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 256 | $0.00 |
| 1036F | 0% | 3,427 | $0.00 | |
| 2001F | 0% | 1,479 | $0.00 | |
| 84436 | 0% | 747 | $0.00 | |
| 90744 | 0% | 307 | $0.00 | |
| 82962 | 0% | 4,166 | $0.00 | |
| H0049 | Alcohol and/or drug screening | 0% | 513 | $0.00 |
| 3008F | 0% | 1,475 | $0.00 | |
| G0467 | Community health center visit, returning patient | 0% | 2,512 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 16,081 | $0.00 |
| 3351F | 0% | 1,155 | $0.00 | |
| D1206 | Topical application of fluoride varnish | 0% | 1,611 | $0.00 |
| G9226 | Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed) | 0% | 1,228 | $0.00 |
| 86762 | 0% | 760 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 3,659 | $0.00 |
| 83002 | 0% | 291 | $0.00 | |
| 82607 | 0% | 1,194 | $0.00 | |
| A4335 | Incontinence supply; miscellaneous | 0% | 226 | $0.00 |
| 80341 | 0% | 28 | $0.00 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 0% | 494 | $0.00 |
| 82435 | 0% | 106 | $0.00 | |
| 84378 | 0% | 151 | $0.00 | |
| 90698 | 0% | 235 | $0.00 | |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 0% | 249 | $0.00 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 1,610 | $0.00 |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | 0% | 79 | $0.00 |
| 90620 | 0% | 177 | $0.00 | |
| 80371 | 0% | 28 | $0.00 | |
| 84132 | 0% | 142 | $0.00 | |
| 83789 | 0% | 40 | $0.00 | |
| 99174 | 0% | 946 | $0.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 28 | $0.00 |
| H2000 | Comprehensive multidisciplinary evaluation | 0% | 182 | $0.00 |
| 88141 | 0% | 141 | $0.00 | |
| 80324 | 0% | 16 | $0.00 | |
| 87522 | Neg quan hep c or qual rna | 0% | 147 | $0.00 |
| 4293F | 0% | 83 | $0.00 | |
| 99383 | 0% | 161 | $0.00 | |
| 80051 | 0% | 175 | $0.00 | |
| 82950 | 0% | 742 | $0.00 | |
| 82784 | 0% | 73 | $0.00 | |
| 84402 | 0% | 29 | $0.00 | |
| 80368 | 0% | 28 | $0.00 | |
| 87046 | 0% | 86 | $0.00 | |
| 91301 | 0% | 50 | $0.00 | |
| 84154 | 0% | 51 | $0.00 | |
| 84075 | 0% | 198 | $0.00 | |
| 82952 | 0% | 161 | $0.00 | |
| 3075F | 0% | 105 | $0.00 | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | 0% | 27 | $0.00 |
| 99406 | 0% | 68 | $0.00 | |
| 99381 | 0% | 41 | $0.00 | |
| 90688 | 0% | 321 | $0.00 | |
| 3079F | 0% | 327 | $0.00 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 0% | 370 | $0.00 |
| 80358 | 0% | 67 | $0.00 | |
| 86695 | 0% | 98 | $0.00 | |
| 86706 | 0% | 263 | $0.00 | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 0% | 107 | $0.00 |
| 80359 | 0% | 67 | $0.00 | |
| 86255 | 0% | 13 | $0.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 0% | 28 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 167 | $0.00 |
| 82270 | 0% | 12 | $0.00 | |
| 97014 | 0% | 19 | $0.00 | |
| 3044F | 0% | 126 | $0.00 | |
| 86160 | 0% | 116 | $0.00 | |
| 86225 | 0% | 73 | $0.00 | |
| 80367 | 0% | 28 | $0.00 | |
| 82040 | 0% | 191 | $0.00 | |
| 1034F | 0% | 34 | $0.00 | |
| 64450 | 0% | 12 | $0.00 | |
| T1014 | Telehealth transmission, per minute, professional services bill separately | 0% | 31 | $0.00 |
| 93320 | 0% | 24 | $0.00 | |
| 87511 | 0% | 149 | $0.00 | |
| 99441 | 0% | 41 | $0.00 | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 0% | 30 | $0.00 |
| 80047 | 0% | 30 | $0.00 | |
| A4217 | Sterile water/saline, 500 ml | 0% | 52 | $0.00 |
| 99070 | 0% | 13 | $0.00 | |
| 17000 | 0% | 31 | $0.00 | |
| 80353 | 0% | 67 | $0.00 | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 0% | 57 | $0.00 |
| 0012A | 0% | 17 | $0.00 | |
| 99385 | 0% | 12 | $0.00 | |
| 80197 | 0% | 18 | $0.00 | |
| 82575 | 0% | 13 | $0.00 | |
| 97804 | 0% | 12 | $0.00 | |
| 80178 | 0% | 13 | $0.00 | |
| 94760 | 0% | 14 | $0.00 | |
| 90732 | 0% | 12 | $0.00 | |
| 99386 | 0% | 17 | $0.00 | |
| 0011A | 0% | 15 | $0.00 | |
| 80357 | 0% | 28 | $0.00 | |
| 86141 | 0% | 14 | $0.00 | |
| S9452 | Nutrition classes, non-physician provider, per session | 0% | 15 | $0.00 |
| 83993 | 0% | 13 | $0.00 | |
| 82985 | 0% | 13 | $0.00 | |
| 84478 | 0% | 12 | $0.00 | |
| 86300 | 0% | 41 | $0.00 | |
| 20610 | 0% | 12 | $0.00 | |
| 87536 | 0% | 15 | $0.00 | |
| 20550 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialARTEAGA, ALBERT (PRESIDENT/ OWNER)
| Provider | Location | Paid |
|---|---|---|
| Lasalle Medical Associates | San Bernardino, CA | $1.50M |
| Lasalle Medical Associates | Fontana, CA | $1.44M |
| Lasalle Medical Associates | San Bernardino, CA | $1.01M |
| Lasalle Medical Associates | Rialto, CA | $85K |
| Lasalle Medical Associates | Victorville, CA | $15K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.